Editorial
Channelopathies and drug discovery in the postgenomic era
Pages (673-674)
Review
The ClC-3 chloride channels in cardiovascular disease
Pages (675-684)
Physiological roles and diseases of tmem16/anoctamin proteins: are they all chloride channels?
Pages (685-692)
Aquaporin-4: orthogonal array assembly, CNS functions, and role in neuromyelitis optica
Pages (702-710)
Calcium-permeable ion channels involved in glutamate receptor-independent ischemic brain injury
Pages (734-740)
Calcium binding protein-mediated regulation of voltage-gated calcium channels linked to human diseases
Pages (741-748)
Targeting ryanodine receptors for anti-arrhythmic therapy
Pages (749-757)
A role of stretch-activated potassium currents in the regulation of uterine smooth muscle contraction
Pages (758-764)
Current understanding of KATP channels in neonatal diseases: focus on insulin secretion disorders
Pages (765–780)
Activation of human ether-a-go-go related gene (hERG) potassium channels by small molecules
Pages (781-788)
Beyond membrane channelopathies: alternative mechanisms underlying complex human disease
Pages (798-804)
Drug discovery for polycystic kidney disease
Pages (805-816)
Propofol and arrhythmias: two sides of the coin
Pages (817-823)
Original Article
Characterization of a critical role for CFTR chloride channels in cardioprotection against ischemia/reperfusion injury
Pages (824-833)
CFTR chloride channel as a molecular target of anthraquinone compounds in herbal laxatives
Pages (834-839)
Pregnant phenotype in aquaporin 8-deficient mice
Pages (840-844)
